Echo Therapeutics unveils results from the multi-center clinical trial of its Symphony continuous glucose monitoring system. Echo Therapeutics (NSDQ:ECTE) revealed results for its Symphony continuous glucose monitoring system, touting positive findings from the CE Mark regulatory trial. Symphony is a non-invasive, wireless system designed to provide accurate, real-time blood glucose data for patients in hospital critical care settings.
Help employers find you! Check out all the jobs and post your resume.
